可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 王月刚,吴平生. 干细胞移植治疗冠心病的应用进展[J]. 心脏杂志, 2007, 19(1):91-95.
[2] Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses[J]. Blood, 2005, 105(4):1815-1822.
[3] Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction[J]. Proc Natl Acad Sci USA, 2005, 102(32):11474-11479.
[4] Tang YL, Zhao Q, Zhang YC, et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium[J]. Regul Pept, 2004, 117(1):3-10.
[5] Ruixing Y, Jiaquan L, Jie C, et al. Intravenous administration of vascular endothelial growth factor improves cardiac performance and inhibits cardiomyocyte apoptosis[J]. Growth Factors, 2006, 24(3):209-217.
[6] Yang Z, Wang W, Ma D, et al. Recruitment of stem cells by hepatocyte growth factor via intracoronary gene transfection in the postinfarcion heart failure[J]. Sci China C Life Sci, 2007, 50(6):748-752.
[7] 王东侠,谭茗月. 促红细胞生成素在心血管疾病中的应用进展[J]. 心脏杂志, 2007, 19(3):342-344.
[8] Abdelrahman M, Sharples EJ, McDonald MC, et al. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia[J]. Shock, 2004, 22(1):63-69.
[9] Lipsic E, van der Meer P, Henning RH, et al. Timing of erythropoietin treatment of cardioprotection in ischemia/reperfusion[J]. J Cardiovasc Pharmacol, 2004, 44(4):473-479.
[10]Nishiya D, Omura T, Shimada K, et al. Effects of erythropoietin on cardiac remodeling after myocardial infarction[J]. J Pharmacol Sci, 2006, 101(1):31-39.
[11]张定国,张馥敏,张郁清,等. 促红细胞生成素经磷酸酰肌醇-3-激酶/蛋白激酶B途径增强自体骨髓间充质干细胞移植治疗大鼠心肌梗死的作用[J]. 中华心血管病杂志, 2006, 34(10):912-916.
[12]Gao F, He T, Wang H, et al. A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats[J]. Can J Cardiol, 2007, 23(11):891-898.